Kuwait vs Netherlands: The number of people with susceptibility test result for rifampicin
Kuwait
401
in 2021
Netherlands
270
in 2021
Kuwait rank
85th
Netherlands rank
88th
The number of people with susceptibility test result for rifampicin over time
- Kuwait
- Netherlands
How they compare
Kuwait currently reports 401 against 270 in Netherlands, a difference of 131.
That makes Kuwait's figure about 1.5 times Netherlands's.
Across all 5 years both countries report, Kuwait has been ahead every year.
Kuwait ranks 85th and Netherlands ranks 88th of 155 countries.
Kuwait has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kuwait | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 346.33 | 322.33 | 24 | Kuwait |
| 2020s | 350 | 257 | 93 | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kuwait or Netherlands?
- Kuwait, at 401 against 270 in Netherlands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kuwait and Netherlands?
- 131, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do Kuwait and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- Kuwait ranks 85th and Netherlands ranks 88th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.